Loading organizations...
Lion Capital operates as a specialized private equity firm, primarily focusing its investment efforts on the consumer sector. The firm's core activity involves acquiring and nurturing established consumer brands, along with identifying and supporting innovative businesses that respond to evolving consumer habits and market trends. Their strategic approach combines capital investment with operational guidance to enhance brand value and drive sustainable growth.
The company was founded by Lyndon Lea and Robert Darwent. Its origins trace back to 1998 when it began as the European affiliate of the American private equity firm Hicks Muse Tate & Furst. Lea and Darwent subsequently spearheaded the separation of this European operation, establishing Lion Capital as an independent entity dedicated to consumer-focused investments.
Lion Capital targets companies within the broad consumer landscape, seeking opportunities where their expertise can catalyze significant transformation. The firm's long-term vision is to build a portfolio of leading consumer businesses by leveraging deep industry insight and a hands-on approach to foster enduring success and market leadership for the brands it partners with.
Lions Capital has 1 tracked investment across 1 company. The latest tracked deal is $13.0M Series A in Kanvas Biosciences in June 2024.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jun 1, 2024 | Kanvas Biosciences | $13.0M Series A | Dcvc (data Collective), Lions Capital | Matt Ocko |